Uptake of sulfate conjugates by isolated rat hepatocytes

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 792-798

  Hassen, Abdullah M ^a   Lam, Dennis ^a   Chiba, Masato ^a,b   Tan, Eugene ^a   Geng, Wanping ^a   Pang, K Sandy ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ANTIMYCIN A1; CHOLINE; ESTRONE SULFATE; HARMOL; HYMECROMONE SULFATE; OUABAIN; POTASSIUM CYANIDE; ROTENONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG CONJUGATION; DRUG METABOLISM; DRUG SULFATION; DRUG TRANSPORT; DRUG UPTAKE; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLINE; ESTROGENS, CONJUGATED (USP); ESTRONE; HARMINE; HYMECROMONE; LIVER; MALE; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030056045     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. A. E. Buhl, D. J. Waldon, C. A. Baker, and G. A. Johnson: Minodoxil sulfate is the active metabolite that stimulate hair follicles. J. Invest. Dermatol. 95, 553-557 (1990).
2. J. R. De Baun, J. Y. R. Smith, E. C. Miller, and J. A. Miller: Reactivity in vivo of the carcinogen, N-2-acetylaminoflourene: increase by sulfate ion. Science 67, 184-185 (1971).
3. R. J. Santen, D. Leszcynkski, N. Tilson-Mallet, P. D. Feil, C. Wright, A. Manni, and S. J. Santner: Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann. N.Y. Acad. Sci. 464, 126-137 (1986).
4. T. C. Bartholomew and B. H. Billing: The effect of 3-sulphation and taurine conjugation on the uptake of chenodeoxycholic acid by rat hepatocytes. Biochim. Biophys. Acta 754, 101-109 (1983).
5. I. Yousef, D. Mignault, and B. Tuchweber: Effect of complete sulfation of bile acids on bile formation: role of conjugation and number of sulfate groups. Hepatology 15, 438-445 (1992).
6. K. S. Pang, A. J. Schwab, C. A. Goresky, and M. Chiba: Transport, binding and metabolism of sulfate conjugates in the liver. Chem. Biol. Interact. 92, 179-207 (1994).
7. M. El Mouelhi and F.C. Kauffman: Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver. Hepatology 6, 450-456 (1986).
8. G. Strobel, E. Werle, and H. Weicker: Isomer specific kinetics of dopamine β-hydroxylase and arylsulfatase toward catecholamine sulfates. Biochem. Int. 20, 343-351 (1990).
9. L. Duncan, A. Purohit, M. Howarth, B. V. L. Potter, and M. J. Reed: Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 53, 298-303 (1993).
10. M. Schwenk and V. L. del Pino: Uptake of estrone sulfate by isolated rat liver cells. J. Steroid Biochem. 13, 669-673 (1980).
11. +-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles. J. Pharmocol. Exp. Ther. 250, 301-308 (1989).
12. W. J. Brock, S. Durham, and M. Vore: Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes: lack of correlation between cholestasis and inhibition of taurocholate uptake, J. Steroid Biochem. 20, 1181-1185 (1984).
13. G. Soderqvist, H. Olsson, N. Wilking, B. von Schoultz, and K. Carlstrom: Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives. J. Steroid Biochem. 48, 221-224 (1994).
14. S. W. Sundheimer and K. Brendel: Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes. Drug Metab. Dispos. 11, 433-440 (1983).
15. S. Iida, T. Mizuma, N. Sakuma, M. Hayashi, and S. Awazu: Transport of acetaminophen conjugates in isolated rat hepatocytes. Drug Metab. Dispos. 17, 341-344 (1988).
16. C. A. Goresky, K. S. Pang, A. J. Schwab, F. Barker III, W. Cherry, and G. G. Bach: Protein binding effects in acetaminophen sulfate entry into perfused liver. Hepatology 16, 173-190 (1992).
17. S. Miyauchi, Y. Sugiyama, T. Iga, and M. Hanano: Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats. J. Pharm. Sci. 77, 688-692 (1988).
18. S. Ratna, M. Chiba, L. Bandyopadhay, and K. S. Pang: Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver. Hepatology 17, 836-853 (1993).
19. M. Chiba, J. Hollands, A. J. Schwab, C. A. Goresky, and K. S. Pang: Prograde and retrograde perfusion of 4-methylumbelliferyl sulfate: multiple indicator dilution studies in perfused rat liver. Hepatology 8, 295A, Abstract 956 (1993).
20. A. Dietmeier, R. Gasser, J. Graf, and M. Peterlik: Investigations on the sodium dependence of bile acid fluxes in the isolated perfused rat liver. Biochim. Biophys. Acta 443, 81-91 (1976).
21. + on bile acid uptake by isolated rat hepatocytes: evidence for a heterogeneous system. Hoppes-Seyler's Z. Physiol. Chem. 359, 181-192 (1978).
22. Y. Laperche, A. M. Preaux, and P. Berthelot: Two systems are involved in the sulfobromophthalein uptake by rat liver cells: one is shared with bile salts. Biochem. Pharmacol. 30, 1333-1336 (1981).
23. M. Frimmer and K. Ziegler: The transport of bile acids in liver cells. Biochim. Biophys. Acta 947, 75-99 (1988).
24. +-bile acid cotransport system. Proc. Natl. Acad. Sci. U.S.A. 88, 10629-10633 (1991).
25. B. Hagenbuch and P. J. Meier: Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J. Clin. Invest. 93, 1326-1331 (1994).
26. - on organic anion transport in short-term cultured rat hepatocytes and isolated rat liver. J. Clin. Invest. 79, 1259-1268 (1987).
27. E. Jacquemin, B. Hagenbuch, B. Stieger, A. W. Wolkoff, and P. J. Meier: Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes. J. Clin. Invest. 88, 2146-2149 (1991).
28. +-independent organic anion transporter. Proc. Natl. Acad. Sci. U.S.A. 91, 133-137 (1994).
29. G.-A. Kullack-Ublick, B. Hagenbuch, B. Stieger, A. W. Wolkoff, and P. J. Meier. Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 20, 411-416 (1994).
30. G. Hugentobler and P. J. Meier: Multispecific anion exchange in basolateral (sinusoidal) rat liver plasma membrane vesicles. Am. J. Physiol. 251, G656-G664 (1986).
31. C. Tiribelli, G. C. Lunazzi, and G. L. Sottocasa: Mechanism of hepatic uptake of organic anions. Clin. Sci. 71, 1-8 (1986).
32. P. D. Berk, B. J. Potter, and W. Stremmel: Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology 7, 165-176 (1987).
33. A. Tsuji, T. Terasaki, K. Takanosu, I. Tamai, and E. Nakashima: Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Biochem. Pharmocol. 35, 151-158 (1986).
34. M. Yamazaki, Y. Sugiyama, H. Suzuki, T. Iga, and M. Hanano: Utilization of ATP-depleted cells in the analysis of taurocholate uptake by isolated rat hepatocytes. J. Hepatol. 14, 54-63 (1992).
35. P. F. Shanley, M. Brezis, K. Spokes, P. Silva, F. H. Epstein, and S. Rosen: Differential responsiveness in proximal tubule segments to metabolic inhibitors in the isolated perfused rat kidney. Am. J. Kidney Dis. 7, 76-83 (1986).
36. S. Cheng and D. Levy: Characterization of the anion transport system in hepatocyte plasma membranes. J. Biol. Chem. 255, 2637-2640 (1980).
37. +-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol. 264 (Gastrointest. Liver Physiol. 27), G36-G44 (1993).
38. G. J. Mulder and A. H. Hagerdoorn: UDP glucuronyltransferase and phenol-sulfotransferase in vivo and in vitro. Conjugation of harmol and harmolol. Biochem. Pharmacol. 23, 2101-2109 (1974).
39. C. L. Zimmerman, S. Ratna, E. Leboeuf, and K. S. Pang: High-performance liquid chromatographic method for the direct determination of 4-methylumbelliferone and its glucuronide and sulfate conjugates: application to studies in the single-pass in situ perfused rat intestine-liver preparation. J. Chromatogr. 563, 83-94 (1991).
40. J. Jorritsima, J. H. N. Meerman, R. J. Vonk, and G. J. Mulder: Biliary and urinary excretion of drug conjugates: effect of diuresis and choloresis on excretion of harmol sulphate and harmol glucuronide in the rat. Xenobiotica 9, 247-252 (1979).
41. P. Moldéus, J. Hogberg, and S. Orrenius: Isolation and use of liver cells. Methods Enzymol. 52, 60-71 (1978).
42. P. O. Seglen: Preparation of isolated rat liver cells. Methods Cell Biol. 13, 29-83 (1976).
43. H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff: Statistical estimates in pharmacokinetics. J. Pharmacokinet. Biopharm. 2, 123-148 (1974).
44. T. M. Ludden, S. L. Beal, and L. B. Sheiner: Comparison of the Akaike information criteria, the Schwarz criterion, and the F test as guides to model selection J. Pharmacokinet. Biopharm. 22, 431-445 (1994).
45. D. L. Loriaux, H. J. Ruder, and M. B. Lipsett: The measurement of estrone sulfate in plasma. Steroids 18, 463-472 (1971).